Skip to main content

Table 5 Subgroup analyses of HCT2 and ROP patients

From: Association between hematocrit in the first two hours of life and retinopathy during prematurity: a retrospective study from DRYAD

Subgroup

Variable

n.total

n.event_%

crude.OR_95CI

crude.P_value

adj.OR_95CI

adj.p_value

p.for.interaction

GA(w)

        

<28

HCT2

92

53 (57.6)

0.95 (0.88 ~ 1.03)

0.188

1.01 (0.9 ~ 1.14)

0.819

0.024

≥ 28

HCT2

234

25 (10.7)

0.81 (0.75 ~ 0.88)

< 0.001

0.85 (0.76 ~ 0.96)

0.006

 

BW(g)

        

<1000

HCT2

81

50 (61.7)

0.93 (0.85 ~ 1.02)

0.124

0.99 (0.84 ~ 1.16)

0.892

0.073

≥ 1000,<1500

HCT2

112

24 (21.4)

0.87 (0.8 ~ 0.95)

0.001

0.85 (0.73 ~ 0.97)

0.02

 

≥ 1500

HCT2

133

4 (3)

0.78 (0.66 ~ 0.93)

0.006

0 (0 ~ 0)

< 0.001

 

Sex

        

female

HCT2

122

31 (25.4)

0.84 (0.77 ~ 0.91)

< 0.001

0.91 (0.81 ~ 1.02)

0.114

0.733

male

HCT2

204

47 (23)

0.83 (0.77 ~ 0.89)

< 0.001

0.95 (0.86 ~ 1.05)

0.283

 

Delivery Mode

        

Cesarean section

HCT2

196

52 (26.5)

0.85 (0.8 ~ 0.9)

< 0.001

0.98 (0.9 ~ 1.08)

0.718

0.563

Vaginal delivery

HCT2

130

26 (20)

0.8 (0.72 ~ 0.88)

< 0.001

0.84 (0.73 ~ 0.97)

0.018